Shyam Medical Stores

A 10mg Tesamorelin vial from "Peptide Sciences" contains Tesamorelin, a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It is designed to stimulate the pituitary gland to produce and release more of the body's own growth hormone (GH), which in turn increases levels of insulin-like growth factor-1 (IGF-1).

The primary FDA-approved use for Tesamorelin (under the brand name Egrifta) is to reduce excess abdominal fat, specifically visceral adipose tissue (VAT), in HIV-infected adult patients with lipodystrophy. Lipodystrophy is a condition characterized by abnormal fat distribution and metabolic changes, often linked to antiretroviral therapy for HIV. Tesamorelin is not a weight-loss drug and should not be used for general obesity.

SS-31 works by readily penetrating cell membranes and concentrating in the inner mitochondrial membrane, where it binds reversibly to cardiolipin. Cardiolipin is a phospholipid crucial for maintaining mitochondrial structure and function, including electron transport and ATP production. By stabilizing cardiolipin and the mitochondrial membrane, SS-31 enhances ATP (energy) production, improves electron transfer, reduces the generation of harmful reactive oxygen species (ROS), and inhibits the opening of the mitochondrial permeability transition pore, which can lead to cell death.

A 5mg Sermorelin injection typically refers to a dosage of Sermorelin, a synthetic peptide that mimics the naturally occurring growth hormone-releasing hormone (GHRH). It is designed to stimulate the pituitary gland to produce and release more of the body's own human growth hormone (HGH).

Sermorelin acetate is a synthetic analog of GHRH, consisting of the first 29 amino acids of natural human GHRH. Its primary use, and what it was originally FDA-approved for, is the diagnosis and treatment of poor growth in children due to inadequate secretion of endogenous growth hormone. While the commercial drug was discontinued for business reasons, not safety or efficacy concerns, it is now available as a compounded medication prepared by specialty pharmacies.

A 5mg TB-500 vial from "Peptide Sciences" contains TB-500, which is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring protein present in virtually all human and animal cells. Tβ4 plays a crucial role in cell migration, differentiation, and survival, making it a key player in tissue repair, regeneration, and protection.

TB-500's primary mechanism of action involves promoting cell migration (especially of endothelial and keratinocyte cells), stimulating angiogenesis (the formation of new blood vessels), reducing inflammation, and regulating actin polymerization, which is essential for cell movement and structural integrity. These actions contribute to its powerful regenerative and healing properties.

A 2mg Tesamorelin vial from "Peptide Sciences" contains Tesamorelin, a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It is designed to stimulate the pituitary gland to produce and release more of the body's own growth hormone (GH), which in turn increases levels of insulin-like growth factor-1 (IGF-1).

The primary FDA-approved use for Tesamorelin (under the brand name Egrifta) is to reduce excess abdominal fat, specifically visceral adipose tissue (VAT), in HIV-infected adult patients with lipodystrophy. Lipodystrophy is a condition characterized by abnormal fat distribution and metabolic changes, often linked to antiretroviral therapy for HIV. Tesamorelin is not a weight-loss drug and should not be used for general obesity.

A 10mg TB-500 vial from "Peptide Sciences" contains TB-500, which is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring protein present in virtually all human and animal cells. Tβ4 plays a crucial role in cell migration, differentiation, and survival, making it a key player in tissue repair, regeneration, and protection.

TB-500's primary mechanism of action involves promoting cell migration (especially of endothelial and keratinocyte cells), stimulating angiogenesis (the formation of new blood vessels), reducing inflammation, and regulating actin polymerization, which is essential for cell movement and structural integrity. These actions contribute to its powerful regenerative and healing properties.

When considering retatrutide and its various dosages, such as 10 mg, it's crucial to remember that this is an investigational drug still undergoing clinical trials. Therefore, dosage information is primarily found within the context of those trials. 

10mg Epithalon Vial from Peptide Sciences contains the synthetic peptide epithalon (Ala-Glu-Asp-Gly), which is being researched for its potential effects on aging through its influence on the pineal gland and melatonin production. Some studies suggest it may increase telomere length and have antioxidant properties. It is typically sold for research purposes.

20mg Epithalon Vial Peptide Sciences refers to a specific product containing the synthetic peptide Epithalon (also known as Epitalon) in a 20mg vial, manufactured or distributed by a company operating under the name "Peptide Sciences" or similar.

Epithalon is a tetrapeptide with the molecular formula C14H22N4O9 and a molecular weight of 390.3459. It is known to stimulate telomerase, an enzyme that helps maintain the length of telomeres, the protective caps at the ends of chromosomes. As telomeres naturally shorten with age, Epithalon's potential to extend them has led to its study in the context of anti-aging and longevity.

A "5mg Hexareline Vial Peptide Sciences" refers to a product containing 5 milligrams of Hexareline, a synthetic peptide, typically supplied in a sealed glass vial, and associated with the brand "Peptide Sciences" or similar.

Hexareline (HEX) is a synthetic hexapeptide, meaning it's composed of six amino acids. It belongs to a class of compounds known as Growth Hormone-Releasing Peptides (GHRPs) or Growth Hormone Secretagogues (GHS).

A 10mg vial of GHRP-6 from Peptides Sciences typically contains the peptide in a lyophilized (freeze-dried) powder form. GHRP-6, or Growth Hormone Releasing Peptide-6, is a synthetic hexapeptide that functions as a growth hormone secretagogue. It stimulates the pituitary gland to release natural growth hormone (GH) by binding to the ghrelin receptor. This action leads to an increase in circulating GH levels in the body.

In research settings, GHRP-6 has been investigated for its potential effects on various physiological processes. These include its ability to enhance protein synthesis, promote lean muscle tissue growth, contribute to fat loss by increasing the metabolism of fat cells, and potentially aid in tissue repair and regeneration. It has also been studied for its effects on appetite regulation, as it mimics the action of ghrelin, a hormone known to stimulate hunger. Some research also suggests it may improve sleep quality, reduce inflammation, and enhance bone density.

A "CJC-1295 DAC Vial Peptide Sciences" indicates a product containing the synthetic peptide CJC-1295 modified with a Drug Affinity Complex (DAC), typically provided in a sealed vial, and associated with the brand "Peptide Sciences" or a similar supplier.

CJC-1295 DAC is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), a naturally occurring hormone produced in the hypothalamus that stimulates the pituitary gland to release growth hormone (GH). The distinguishing feature of CJC-1295 DAC is its "DAC" modification.

A "5mg BPC-157 Vial Peptide Sciences" indicates a product containing 5 milligrams of the synthetic peptide BPC-157, typically supplied in a sealed vial, and associated with a brand name like "Peptide Sciences."

BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide, meaning it's composed of 15 amino acids. It's derived from a naturally occurring protein found in human gastric juice. BPC-157 has garnered significant interest in the research community due to its remarkable regenerative and protective properties observed primarily in preclinical (animal) studies.